The purpose of the session is to emphasize key elements that enable radiologists to maximize the quality and effectiveness of a lung cancer screening program as early programs begin to stabilize and mature during the second year of Medicare coverage. Topics to be covered include recent results and analyses of large scale clinical trials of lung cancer screening, methods and evolving issues related to the application of the ACR LungRADs interpretation schema, implementing quality assurance and improvement into a lung cancer screening program, and the use of information technology solutions (PACS, RIS, EMR, and revenue cycle IT) to empower a lung cancer screening program. This session will provide new and more advanced topics as compared to the lung cancer screening session presented during ACR2015, but will be relevant for those just beginning a new program. Developed in conjunction with the Fleischner Society and the Society for Thoracic Radiology.
Phillip Boiselle: None
Ella Kazerooni: None
Jo-Anne Shepard: None
Eliot Siegel: Consultant-IBM; Honorarium-Bayer Healthcare; Stock Options-Merge Healthcare; Officer, Director-Carestream Health; Research Grants-NIH
You must be logged in and own this session in order to post comments.